Correspondence regarding the paper “Laorden D, Zamarrón E, Romero D, Domínguez-Ortega J, Villamañán E, Losantos I, Gayá F, Quirce S, Álvarez-Sala R. evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R. Respir. Med. 2023; 211: 107216”

We have read with great interest the recent study by Laorden et al., “Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R” [1]. While their study provides valuable insights into using the FEOS score proposed by Perez de Llano et al. [2] and super-responder criteria defined by Upham et al. [3], some points require further analysis.

Source: Respiratory Medicine - May 9, 2023 Category: Respiratory Medicine Authors: Miguel Estrav ís, Jacqueline Pérez-Pazos, Maria J. Martin, Jacinto Ramos-González, María Gil-Melcón, Cristina Martín-García, Asunción García-Sánchez, Catalina Sanz, Ignacio Dávila Tags: Correspondence Source Type: research